The presence of the -866A/55Val/Ins haplotype in the uncoupling protein 2 (UCP2) gene is associated with decreased UCP2 gene expression in human retina

Experimental Eye Research

Volumn 94, Issue 1, 2012, Pages 49-55

  de Souza, Bianca M ^a,b   Assmann, Taís S ^a   Kliemann, Lúcia M ^a   Marcon, Alexandre S ^c   Gross, Jorge L ^a,b   Canani, Luís H ^a,b   Crispim, Daisy ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Dermatology Service Santa Casa de Misericórdia de Porto Alegre Hospital Complex   (Brazil)

Author keywords

Diabetic retinopathy; DNA polymorphism; Haplotype; Human retina; Uncoupling protein 2 gene expression

Indexed keywords

BETA ACTIN; MNSOD2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ADULT; ALLELE; ARTICLE; CADAVER DONOR; CORNEA; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; INDEL MUTATION; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TISSUE DONORS;

EID: 84855845501     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.11.004     Document Type: Article

References (35)

1. Applied Biosystems Relative Quantitation of Gene Expression Experimental Design and Analysis: Relative Standard Curve Method and Comparative ct Method (DeltaDelta-ct). Guide to Performing Relative Quantitation of Gene Expression Using Real-time Quantitative PCR 2004, Applied Biosystems, Foster City, 34-49 pp.
2. Azzu V., Brand M. The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem. Sci. 2010, 35:298-307.
3. Brand M., Affourtit C., Esteves T., Green K., Lambert A., Miwa S., Pakay J., Parker N. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med. 2004, 37:755-767.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
5. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
6. Cassell P., Neverova M., Janmohamed S., Uwakwe N., Qureshi A., McCarthy M., Saker P., Albon L., Kopelman P., Noonan K., Easlick J., Ramachandran A., Snehalatha C., Pecqueur C., Ricquier D., Warden C., Hitman G. An uncoupling protein 2 gene variant is associated with a raised body mass index but not type II diabetes. Diabetologia 1999, 42:688-692.
7. Crispim D., Fagundes N.J., dos Santos K.G., Rheinheimer J., Bouças A.P., de Souza B.M., Macedo G.S., Leiria L.B., Gross J.L., Canani L.H. Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Clin. Endocrinol. (Oxf.) 2010, 72:612-619.
8. Cui Y., Xu X., Bi H., Zhu Q., Wu J., Xia X., Ren Q., Ho P. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp. Eye Res. 2006, 83:807-816.
9. Dhamrait S.S., Stephens J.W., Cooper J.A., Acharya J., Mani A.R., Moore K., Miller G.J., Humphries S.E., Hurel S.J., Montgomery H.E. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur. Heart J. 2004, 25:468-475.
10. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., Harper J.A., Roebuck S.J., Morrison A., Pickering S., Clapham J.C., Brand M.D. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99.
11. Erlanson-Albertsson C. Uncoupling proteins-a new family of proteins with unknown function. Nutr. Neurosci. 2002, 5:1-11.
12. Esterbauer H., Schneitler C., Oberkofler H., Ebenbichler C., Paulweber B., Sandhofer F., Ladurner G., Hell E., Strosberg A.D., Patsch J.R., Krempler F., Patsch W. Acommon polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat. Genet. 2001, 28:178-183.
13. Esteves T., Brand M. The reactions catalysed by the mitochondrial uncoupling proteins UCP2 and UCP3. Biochim. Biophys. Acta 2005, 1709:35-44.
14. Fisler J., Warden C. Uncoupling proteins, dietary fat and the metabolic syndrome. Nutr. Metab. (Lond.) 2006, 3:38.
15. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., Levi-Meyrueis C., Bouillaud F., Seldin M., Surwit R., Ricquier D., Warden C. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 1997, 15:269-272.
16. Fong D., Aiello L., Gardner T., King G., Blankenship G., Cavallerano J., Ferris F., Klein R., American diabetes Association Retinopathy in diabetes. Diabetes Care 2004, 27(Suppl. 1):84-87.
17. Hedrick P.W. Gametic disequilibrium measures: proceed with caution. Genetics 1987, 117:331-341.
18. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993, 11:1026-1030.
19. Jia J.J., Zhang X., Ge C.R., Jois M. The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes. Rev. 2009, 10:519-526.
20. Kanwar M., Chan P.S., Kern T.S., Kowluru R.A. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 2007, 48:3805-3811.
21. Kohner E.M. Diabetic retinopathy. BMJ 1993, 307:1195-1199.
22. Kowluru R.A., Abbas S.N. Diabetes-induced mitochondrial dysfunction in the retina. Invest. Ophthalmol. Vis. Sci. 2003, 44:5327-5334.
23. Kowluru R.A., Atasi L., Ho Y.S. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2006, 47:1594-1599.
24. Liang F.Q., Godley B.F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 2003, 76:397-403.
25. Lindholm E., Klannemark M., Agardh E., Groop L., Agardh C.D. Putative role of polymorphisms in UCP1-3 genes for diabetic nephropathy. J.Diabetes Complications 2004, 18:103-107.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
27. Madsen-Bouterse S.A., Zhong Q., Mohammad G., Ho Y.S., Kowluru R.A. Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic. Res. 2010, 44:313-321.
28. Oberkofler H., Iglseder B., Klein K., Unger J., Haltmayer M., Krempler F., Paulweber B., Patsch W. Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler. Thromb. Vasc. Biol. 2005, 25:604-610.
29. Papa S., Skulachev V. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell Biochem. 1997, 174:305-319.
30. Rudofsky G., Schroedter A., Schlotterer A., Voron'ko O.E., Schlimme M., Tafel J., Isermann B.H., Humpert P.M., Morcos M., Bierhaus A., Nawroth P.P., Hamann A. Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes. Diabetes Care 2006, 29:89-94.
31. Rudofsky G., Schrödter A., Voron'ko O.E., Schlotterer A., Humpert P.M., Tafel J., Nawroth P.P., Bierhaus A., Hamann A. Promoter polymorphisms of UCP1, UCP2, and UCP3 are not associated with diabetic microvascular complications in type 2 diabetes. Horm. Metab. Res. 2007, 39:306-309.
32. Sasahara M., Nishi M., Kawashima H., Ueda K., Sakagashira S., Furuta H., Matsumoto E., Hanabusa T., Sasaki H., Nanjo K. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes 2004, 53:482-485.
33. Stephens M., Smith N.J., Donnelly P. Anew statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
34. Walder K., Norman R.A., Hanson R.L., Schrauwen P., Neverova M., Jenkinson C.P., Easlick J., Warden C.H., Pecqueur C., Raimbault S., Ricquier D., Silver M.H., Shuldiner A.R., Solanes G., Lowell B.B., Chung W.K., Leibel R.L., Pratley R., Ravussin E. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima Indians. Hum. Mol. Genet. 1998, 7:1431-1435.
35. Wang H., Chu W., Lu T., Hasstedt S., Kern P., Elbein S. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2004, 286:1-7.